SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (408)3/20/2002 10:30:27 PM
From: rkrw  Read Replies (2) | Respond to of 496
 
Tuck,
GLFD's aquavan product is what investors should be looking at. Aquavan bolus (onset) results are due out in April is the big if. Even if unfavorable in onset compared to propofol, there's still a sizable market opportunity for the product esp given such a small market cap for glfd. I think glfd is a very interesting stock at this price.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News